A5052984818- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Chronic Disease Management Strategies
- Medication Adherence and Compliance
- Cardiac Health and Mental Health
- Blood Pressure and Hypertension Studies
- Nutritional Studies and Diet
- Potassium and Related Disorders
- Frailty in Older Adults
- Health disparities and outcomes
- Erythropoietin and Anemia Treatment
- Nutrition and Health in Aging
- Atrial Fibrillation Management and Outcomes
- Intensive Care Unit Cognitive Disorders
- Geriatric Care and Nursing Homes
- Iron Metabolism and Disorders
- Diet and metabolism studies
- Health Systems, Economic Evaluations, Quality of Life
- Electronic Health Records Systems
- Cardiovascular Health and Risk Factors
- Congenital Anomalies and Fetal Surgery
- Mobile Health and mHealth Applications
- Dialysis and Renal Disease Management
- Health Policy Implementation Science
Institut Català de la Salut
2015-2025
Universitat Pompeu Fabra
2022-2025
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
2013-2025
Instituto de Salud Carlos III
2014-2025
Universitat de Barcelona
2010-2025
Centre for Biomedical Network Research on Rare Diseases
2025
Centro de Investigación en Red en Enfermedades Cardiovasculares
2023-2025
Hospital Del Mar
2013-2024
Hospital del Mar Research Institute
2013-2024
Centro de Investigación Biomédica en Red
2014-2023
To evaluate the effect of iron deficiency (ID) and/or anaemia on health-related quality life (HRQoL) in patients with chronic heart failure (CHF).We undertook a post-hoc analysis cohort CHF single-centre study evaluating cognitive function. At recruitment, provided baseline information and completed Minnesota Living Heart Failure questionnaire (MLHFQ) for HRQoL (higher scores reflect worse HRQoL). same time, blood samples were taken serological evaluation. ID was defined as serum ferritin...
Heart failure (HF) is frequent and its prevalence increasing. We aimed to evaluate the epidemiologic features of HF patients, 1-year follow-up outcomes independent predictors those at a population level.Population-based longitudinal study including all prevalent cases in Catalonia (Spain) on December 31st, 2012. Patients were divided 3 groups: patients without previous hospitalization, with remote (>1 year) hospitalization recent (<1 admission. analyzed 1year all-cause hospitalizations,...
Background The role of telemedicine in the management patients with chronic heart failure (HF) has not been fully elucidated. We hypothesized that multidisciplinary comprehensive HF care could achieve better results when it is delivered using telemedicine. Methods and In this study, 178 eligible were randomized to either structured follow-up on basis face-to-face encounters (control group, 97 patients) or delivering health (81 patients). Telemedicine included daily signs symptoms based...
There is a paucity of studies providing insights into the progression primary care patients with heart failure and preserved ejection fraction (HFpEF). To investigate characteristics associated mortality rehospitalizations in (HFpEF), previously hospitalized. Retrospective cohort study that included previous (HF) hospitalization ≥50 328 centers Catalonia. Demographic, comorbidities, clinical, treatment variables were collected. Outocomes: Mortality HF rehospitalization. Adjusted Cox...
Background The efficacy of telemedicine in the management patients with chronic heart failure and left ventricular ejection fraction ≥40% is poorly understood. aim our analysis was to evaluate a telemedicine-based intervention specifically these patients, as compared standard care alone. Methods Insuficiència Cardiaca Optimització Remota (iCOR) study single centre, randomised, controlled trial, designed added an existing hospital/primary multidisciplinary, integrated programme for patients....
Abstract Aims The assumption that improved self-care in the setting of heart failure (HF) care necessarily translates into improvements long-term mortality and/or hospitalization is not well established. We aimed to study association between and other major adverse HF events (MAHFE). Methods results conducted an observational, prospective, cohort 1123 consecutive patients with chronic HF. primary endpoint was all-cause mortality. used European Heart Failure Self-care Behaviour Scale 9-item...
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good 1 % wealthy, not 99 unhealthy Andrews A5 The role IDO a...
Decisive information on the parameters involved in cognitive impairment patients with chronic heart failure is as yet lacking. Our aim was to determine functional and psychosocial variables related using mini-mental-state examination (MMSE) age-and education-corrected scores.A cohort study of included an integrated multidisciplinary hospital/primary care program. The MMSE (corrected for age education Spanish population) administered at enrolment Analyses were performed 525 patients....
Information about how patients with advanced heart failure (HF) live and cope their disease remains scarce. The objective of this study was to explore, from phenomenological holistic perspectives, the experiences suffering HF, attended at home in primary care setting 2018.Qualitative conducted 4 healthcare centers Barcelona (Spain). Twelve in-depth interviews were HF patients, aged over 65 visited regularly home. We developed a purposeful sampling, accounting for variability gender, age,...
The potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk cardiovascular events in patients with heart failure during early post-discharge period (ie, vulnerable phase) has not been evaluated our knowledge. We investigated efficacy incorporating mHealth into routine management vulnerable-phase patients. Heart Failure Events Reduction Remote Monitoring eHealth Support (HERMeS) trial was 24-week,...